Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability.
Guerra E, Trerotola M, Relli V, Lattanzio R, Tripaldi R, Ceci M, Boujnah K, Pantalone L, Sacchetti A, Havas KM, Simeone P, Travali N, Querzoli P, Pedriali M, Roversi P, Iezzi M, Tinari N, Antolini L, Alberti S. Guerra E, et al. Among authors: iezzi m. Mol Cancer Ther. 2023 Jun 1;22(6):790-804. doi: 10.1158/1535-7163.MCT-22-0352. Mol Cancer Ther. 2023. PMID: 36921314
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer.
Brocco D, Simeone P, Buca D, Marino PD, De Tursi M, Grassadonia A, De Lellis L, Martino MT, Veschi S, Iezzi M, De Fabritiis S, Marchisio M, Miscia S, Cama A, Lanuti P, Tinari N. Brocco D, et al. Among authors: iezzi m. Cancers (Basel). 2022 Mar 7;14(5):1357. doi: 10.3390/cancers14051357. Cancers (Basel). 2022. PMID: 35267665 Free PMC article.
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma.
Capone E, Lamolinara A, Pastorino F, Gentile R, Ponziani S, Di Vittorio G, D'Agostino D, Bibbò S, Rossi C, Piccolo E, Iacobelli V, Lattanzio R, Panella V, Sallese M, De Laurenzi V, Giansanti F, Sala A, Iezzi M, Ponzoni M, Ippoliti R, Iacobelli S, Sala G. Capone E, et al. Among authors: iezzi m. Cancers (Basel). 2020 Oct 15;12(10):2989. doi: 10.3390/cancers12102989. Cancers (Basel). 2020. PMID: 33076448 Free PMC article.
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy.
Pagotto S, Simeone P, Brocco D, Catitti G, De Bellis D, Vespa S, Di Pietro N, Marinelli L, Di Stefano A, Veschi S, De Lellis L, Verginelli F, Kaitsas F, Iezzi M, Pandolfi A, Visone R, Tinari N, Caruana I, Di Ianni M, Cama A, Lanuti P, Florio R. Pagotto S, et al. Among authors: iezzi m. Cancers (Basel). 2023 Feb 7;15(4):1052. doi: 10.3390/cancers15041052. Cancers (Basel). 2023. PMID: 36831396 Free PMC article. Review.
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer.
Wang J, Lamolinara A, Conti L, Giangrossi M, Cui L, Morelli MB, Amantini C, Falconi M, Bartolacci C, Andreani C, Orlando F, Provinciali M, Del Pizzo FD, Russo F, Belletti B, Riccardo F, Bolli E, Quaglino E, Cavallo F, Amici A, Iezzi M, Marchini C. Wang J, et al. Among authors: iezzi m. Cancers (Basel). 2022 Aug 22;14(16):4054. doi: 10.3390/cancers14164054. Cancers (Basel). 2022. PMID: 36011047 Free PMC article.
186 results